VME.F VIROMED MEDICAL NA O.N.
- Market cap
- EUR 79.1M
- P/E
- -
- P/B
- 9.06x
- ROE
- 5.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is VME.F undervalued?
Graham numberThe Graham number of VIROMED MEDICAL NA O.N. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
VIROMED MEDICAL NA O.N. fundamental analysis
No fundamental analysis for VIROMED MEDICAL NA O.N. yet.
VIROMED MEDICAL NA O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was f…
Full company profileVIROMED MEDICAL NA O.N. financial statements
VIROMED MEDICAL NA O.N. annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 0.00 | 0.00 | 1.12M | 5.09M |
| Gross Profit | - | - | -288K | 2.29M |
| Operating Income | -160K | -359K | -3.50M | -862K |
| EBITDA | -160K | -109K | -3.14M | -9.71K |
| Net Income | -161K | -110K | -3.09M | 605K |
| EPS | - | -0.01 | -0.15 | 0.03 |
| Balance Sheet | ||||
| Total Assets | 20.3M | 20.3M | 13.4M | 13.9M |
| Total Liabilities | 174K | 357K | 4.13M | 3.44M |
| Shareholders' Equity | 20.1M | 20.0M | 9.27M | 10.5M |
| Cash & Short-term Investments | 151K | 195K | 20.6K | 360K |
| Cash Flow | ||||
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 |
| Ratios | ||||
| ROE | -0.8% | -0.6% | -33.4% | 5.8% |
| ROA | -0.8% | -0.5% | -23.1% | 4.3% |
| Net Profit Margin | - | - | -274.9% | 11.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
VIROMED MEDICAL NA O.N. dividends
VIROMED MEDICAL NA O.N. has not paid dividends in the last 4 fiscal years.
Who owns VIROMED MEDICAL NA O.N.
- Insiders 0.00%
- Institutions 0.08%
- Public & others 99.92%
- Shares outstanding 21.3M
VIROMED MEDICAL NA O.N. company profile
- Company name
- VIROMED MEDICAL NA O.N.
- Ticker
- VME.F
- ISIN
- DE000A40ZVN7
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 17
- Fiscal year end
- December
- Address
- Hauptstraße 105, Rellingen, Germany, 25462
- Phone
- 49 4101 809960
- Website
- viromed-medical-ag.de
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was founded in 2021 and is based in Rellingen, Germany.
VIROMED MEDICAL NA O.N. management
1- Mr. Uwe PerbandtMember of Management Board